Direkt zum Inhalt
Merck

Nonpharmacological and nonsurgical approaches in OA.

Best practice & research. Clinical rheumatology (2020-08-11)
Sita Bierma-Zeinstra, Marienke van Middelkoop, Jos Runhaar, Dieuwke Schiphof
ZUSAMMENFASSUNG

Osteoarthritis (OA) is a chronic, disabling, and common disease. Nonpharmacological and nonsurgical treatments are seen as the core treatments for OA. This paper presents an overview of the recommendations from international guidelines on nonpharmacological and nonsurgical interventions. Education, advice, or information about the etiology, progression, prognosis, and treatment options of OA are recommended to be an ongoing and integral part of care. Weight loss (if overweight) is an important core treatment in knee and hip OA. Exercise is a key core treatment in knee, hip, and hand OA and should be considered regardless of age, structural disease severity, functional status, pain levels, or the presence of comorbidities. Walking aids/devices are recommended for both hip and knee OA, while orthoses are recommended for patients with carpometacarpal (CMC) joint OA. Trained healthcare providers with the skills to provide the core treatments are essential. In addition, there should be a proactive management from the first consultation for OA symptoms. Tools for such proactive management and for better uptake of the core interventions are discussed.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Sigma-Aldrich
3,3,4,4,5,5,6,6,7,7,8,8,8-Tridecafluoroctylacrylat, contains inhibitor, 97%